Nerve Repair & Regeneration Market by Product, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

Description

List of Tables

The Global Nerve Repair & Regeneration Market is forecasted to grow significantly, with a projected USD 10,107.24 million in 2023 at a CAGR of 13.25% and expected to reach a staggering USD 24,182.22 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Nerve Repair & Regeneration Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Nerve Repair & Regeneration Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biomaterials and Neurostimulation & Neuromodulation Devices. The Biomaterials is further studied across Nerve Conduits, Nerve Connectors, Nerve Protectors, and Nerve Wraps. The Neurostimulation & Neuromodulation Devices is further studied across External Neurostimulation Devices and Internal Neurostimulation Devices. The Neurostimulation & Neuromodulation Devices commanded largest market share of 67.23% in 2022, followed by Biomaterials.

Based on Application, market is studied across Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries, and Stem Cell Therapy. The Direct Nerve Repair/Neurorrhaphy is further studied across Epineural Repair, Group Fascicular Repair, and Perineural Repair. The Nerve Grafting is further studied across Allografts, Autografts, and Xenografts. The Neurostimulation & Neuromodulation Surgeries commanded largest market share of 35.23% in 2022, followed by Stem Cell Therapy.

Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics. The Hospitals & Clinics commanded largest market share of 78.23% in 2022, followed by Ambulatory Surgery Centers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.23% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Nerve Repair & Regeneration Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Nerve Repair & Regeneration Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nerve Repair & Regeneration Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nerve Repair & Regeneration Market?

4. What is the competitive strategic window for opportunities in the Global Nerve Repair & Regeneration Market?

5. What are the technology trends and regulatory frameworks in the Global Nerve Repair & Regeneration Market?

6. What is the market share of the leading vendors in the Global Nerve Repair & Regeneration Market?

7. What modes and strategic moves are considered suitable for entering the Global Nerve Repair & Regeneration Market?

Product Code: MRR-4316E4E8938A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Nerve Repair & Regeneration Market, by Product, 2022 vs 2030
4.3. Nerve Repair & Regeneration Market, by Application, 2022 vs 2030
4.4. Nerve Repair & Regeneration Market, by End-User, 2022 vs 2030
4.5. Nerve Repair & Regeneration Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Enlarging cases of neurological disorders across the globe
  - 5.1.1.2. Increasing number of peripheral nerve injuries among geriatric population
  - 5.1.1.3. Surging trend of sports and recreational activities
- 5.1.2. Restraints
  - 5.1.2.1. Limited number of neuro surgeons and neuro physicians worldwide
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging innovation in peripheral nerve regeneration techniques
  - 5.1.3.2. Ongoing advancements in tissue engineering and regenerative medicine
- 5.1.4. Challenges
  - 5.1.4.1. Concern regarding functional recovery issues after nerve repair surgery
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Nerve Repair & Regeneration Market, by Product

6.1. Introduction
6.2. Biomaterials
- 6.2.1. Nerve Conduits
- 6.2.2. Nerve Connectors
- 6.2.3. Nerve Protectors
- 6.2.4. Nerve Wraps
6.3. Neurostimulation & Neuromodulation Devices
- 6.3.1. External Neurostimulation Devices
- 6.3.2. Internal Neurostimulation Devices

7. Nerve Repair & Regeneration Market, by Application

7.1. Introduction
7.2. Direct Nerve Repair/Neurorrhaphy
- 7.2.1. Epineural Repair
- 7.2.2. Group Fascicular Repair
- 7.2.3. Perineural Repair
7.3. Nerve Grafting
- 7.3.1. Allografts
- 7.3.2. Autografts
- 7.3.3. Xenografts
7.4. Neurostimulation & Neuromodulation Surgeries
7.5. Stem Cell Therapy

8. Nerve Repair & Regeneration Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals & Clinics

9. Americas Nerve Repair & Regeneration Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Nerve Repair & Regeneration Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Nerve Repair & Regeneration Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Axonics Acquired Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
- 12.3.2. Agreement, Collaboration, & Partnership
  - 12.3.2.1. Minnesota Partnership for Biotechnology and Medical Genomics awarded three collaborative research grants
  - 12.3.2.2. Toyobo launched major marketing initiative for Nerbridge(TM) in the U.S., setting sights on the global nerve conduit market
- 12.3.3. New Product Launch & Enhancement
  - 12.3.3.1. LivaNova introduced SenTiva DUO implantable pulse generator for epilepsy
  - 12.3.3.2. Checkpoint Surgical launched CHECKPOINT GEMINI Bipolar Nerve Stimulator for precise stimulation
  - 12.3.3.3. Checkpoint Surgical introduced new nerve cutting kit
  - 12.3.3.4. Axogen, Inc. Announced Positive Topline Results from Phase 3 RECON(SM) Study for Avance Nerve Graft
- 12.3.4. Investment & Funding
  - 12.3.4.1. BioCircuit Technologies, Inc. Closes a USD 9 million Series Seed Round
  - 12.3.4.2. MicroTransponder received macro funding round with USD 73M for stroke rehab neurostimulator
- 12.3.5. Award, Recognition, & Expansion
  - 12.3.5.1. FDA cleared Neuspera Medical peripheral nerve stim
  - 12.3.5.2. FDA Approves Abbott's Spinal Cord Stimulation For People Living With Painful Diabetic Peripheral Neuropathy
  - 12.3.5.3. BioCircuit Technologies Announced FDA 510(k) Clearance of Nerve Tape Device

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing